Enxin Wang

No.569 Xinsi Road
Xi'an, 710038, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

ASO Visual Abstract: Identifying the Optimal Treatment for Patients with Hepatocellular Carcinoma and Clinically Significant Portal Hypertension: a Multicenter Propensity Score-Weighted Analysis.

ASO Visual Abstract: Identifying the Optimal Treatment for Patients with Hepatocellular Carcinoma and Clinically Significant Portal Hypertension: a Multicenter Propensity Score-Weighted Analysis.

Journal: Annals of surgical oncology

Published: December 26, 2025

Combining Transarterial Chemoembolization with Sorafenib Improves Survival in Selected Patients with Hepatocellular Carcinoma and Extrahepatic Spread: A Multicenter Real-World Study.

Combining Transarterial Chemoembolization with Sorafenib Improves Survival in Selected Patients with Hepatocellular Carcinoma and Extrahepatic Spread: A Multicenter Real-World Study.

Journal: Journal of hepatocellular carcinoma

Published: October 30, 2025

Identifying the Optimal Treatment for Patients with Hepatocellular Carcinoma and Clinically Significant Portal Hypertension: A Multicenter Propensity Score-Weighted Analysis.

Identifying the Optimal Treatment for Patients with Hepatocellular Carcinoma and Clinically Significant Portal Hypertension: A Multicenter Propensity Score-Weighted Analysis.

Journal: Annals of surgical oncology

Published: August 18, 2025

Liver resection versus interventional treatments for hepatocellular carcinoma patients with hypohepatia: a multicenter study.

Liver resection versus interventional treatments for hepatocellular carcinoma patients with hypohepatia: a multicenter study.

Journal: Surgical endoscopy

Published: March 17, 2025

Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆.

Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆.

Journal: JHEP reports : innovation in hepatology

Published: December 15, 2023

Potential candidates for liver resection in liver-confined advanced HCC: a Chinese multicenter observational study.

Potential candidates for liver resection in liver-confined advanced HCC: a Chinese multicenter observational study.

Journal: Frontiers in oncology

Published: February 21, 2023

Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study.

Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study.

Journal: Frontiers in oncology

Published: July 01, 2022

Correction to: Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.

Correction to: Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.

Journal: The American journal of gastroenterology

Published: December 09, 2021

Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study.

Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study.

Journal: Liver cancer

Published: October 24, 2021

Clinical course and outcomes of COVID-19 patients with chronic obstructive pulmonary disease: A retrospective observational study in Wuhan, China.

Clinical course and outcomes of COVID-19 patients with chronic obstructive pulmonary disease: A retrospective observational study in Wuhan, China.

Journal: Medicine

Published: October 12, 2021

Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization.

Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization.

Journal: European radiology

Published: September 23, 2021

Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS.

Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS.

Journal: JHEP reports : innovation in hepatology

Published: July 17, 2021

Showing 1-12 of 33

Last Updated: 09/26/2026